Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05598099
Other study ID # B4DT-PTSD1
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2022
Est. completion date January 10, 2025

Study information

Verified date October 2022
Source Haukeland University Hospital
Contact Anders L Thorsen, PhD
Phone 90367617
Email anders.lillevik.thorsen@helse-bergen.no
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Post-traumatic stress disorder (PTSD) is a prevalent and disabling condition. Trauma-focused psychotherapy, including cognitive behavioural therapy (CBT), are among the recommended first-line treatment alternatives. However, a substantial proportion of patients decline, drop-out or do not respond to current psychotherapies. Previous research suggests that intensive or concentrated formats of trauma-focused psychotherapy can lead to faster recover and lower attrition, but there are currently few studies of these approaches. The current study will investigate the acceptability. treatment satisfaction and preliminary changes in symptoms after four consecutive days of concentrated CBT for PTSD.


Description:

The study will investigate the research questions in three stages. In the first stage four patients will be treated individually. In the second stage two groups of four patients will be treated, with at least a 1:1 ratio between therapists and patients per group. In the third stage 30 patients will be treated in groups of about four patients per group, with at least a 1:1 ratio between therapists and patients per group. The primary outcome measure is changes in PTSD-related symptoms as measured using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). Acceptability will be measured as the proportion of patients accepting treatment when offered, while attrition is measured as the proportion of patients that withdraw from treatment after it has started. Several other measures will be collected to measure treatment satisfaction, related symptoms, and functional impairment.


Recruitment information / eligibility

Status Recruiting
Enrollment 42
Est. completion date January 10, 2025
Est. primary completion date January 10, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - fulfills DSM-5 criteria for PTSD - One or more single traumas in adolescence or adulthood - Speaks and writes Norwegian Exclusion Criteria: - New or unstable psychopharmacological treatment within last four weeks - fulfills ICD-11 criteria for complex PTSD - Ongoing substance abuse - Ongoing danger of suicide - Ongoing borderline personality disorder - Ongoing psychosis - Intellectual disability

Study Design


Intervention

Behavioral:
Concentrated cognitive behavioral therapy
A psychological intervention consisting of psychoeducation and exposure therapy with the goal of changing the tolerability and negative interpretations of post-traumatic symptoms. The treatment is tailored to the individual patient through all stages, including relapse prevention and planning how to use treatment principles in daily life

Locations

Country Name City State
Norway Haukeland University Hospital Bergen Vestland

Sponsors (2)

Lead Sponsor Collaborator
Haukeland University Hospital University of Bergen

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Clinician-administered interview to diagnose and the severity of PTSD Change in scores from before treatment to one week after treatment
Primary Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Clinician-administered interview to diagnose and the severity of PTSD Change in scores from one week after treatment to three months after treatment
Primary Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Clinician-administered interview to diagnose and the severity of PTSD Change in scores from three months after treatment to twelve months after treatment
Secondary Client Satisfaction Questionnaire 8 (CSQ-8) Patient-rated questionnaire of treatment satisfaction One week after treatment
Secondary Client Satisfaction Questionnaire 8 (CSQ-8) Patient-rated questionnaire of treatment satisfaction Three months after treatment
Secondary Client Satisfaction Questionnaire 8 (CSQ-8) Patient-rated questionnaire of treatment satisfaction Twelve months after treatment
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03962504 - Written Exposure Therapy Versus Prolonged Exposure: a Non-inferiority Trial N/A
Completed NCT01995123 - Behavioral Activation for Smoking Cessation in PTSD N/A
Not yet recruiting NCT06278922 - Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma N/A
Completed NCT04597450 - Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) Phase 1
Completed NCT03593772 - Mission Reconnect- Delivering a Mobile and Web Based Self Directed Complementary And Integrative Health Program to Veterans and Their Partners to Manage Pain and PTSD N/A
Completed NCT03429166 - Connecting Women to Care: Home-based Psychotherapy for Women With MST Living in Rural Areas N/A
Recruiting NCT04317820 - Deep Brain Reorienting in Post-traumatic Stress Disorder N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT03504722 - Evaluating the Feasibility of RESCUE: An Adjunctive HAI-Based Intervention for Veterans With PTSD N/A
Completed NCT04305353 - Intensive Care Unit (ICU) Diary Project N/A
Completed NCT03113890 - McLean and Genomind Prospective Study N/A
Withdrawn NCT05173831 - Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans Phase 2
Withdrawn NCT03924297 - Chilipad for Sleep and Symptoms of PTSD N/A
Not yet recruiting NCT04056767 - Changes in Digital Phenotype During PE Therapy
Completed NCT03158558 - Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD N/A
Completed NCT03343028 - Biomarker Establishment for Superior Treatment of PTSD
Withdrawn NCT03216356 - Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD Phase 2/Phase 3
Completed NCT02370173 - A Non-Pharmacological Method for Enhancing Sleep in PTSD N/A
Completed NCT01955538 - The Effect of BAT Versus Mixed Physical Activity as add-on Treatment for Traumatised Refugees. Phase 3
Completed NCT01911585 - Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure N/A